---
figid: PMC9455726__ijms-23-09540-g005
figtitle: Dysfunctional Glucose Metabolism in Alzheimer’s Disease Onset and Potential
  Pharmacological Interventions
organisms:
- NA
pmcid: PMC9455726
filename: ijms-23-09540-g005.jpg
figlink: /pmc/articles/PMC9455726/figure/ijms-23-09540-f005/
number: F5
caption: Proteolytic cleavage of APP. In the non-amyloidogenic pathway, the extracellular
  domain cleavages by α-secretase and releases the soluble peptide sAPPα. In contrast,
  the amyloidogenic pathway releases Aβ42, a significant component of Aβ plaques.
papertitle: Dysfunctional Glucose Metabolism in Alzheimer’s Disease Onset and Potential
  Pharmacological Interventions.
reftext: Vijay Kumar, et al. Int J Mol Sci. 2022 Sep;23(17):9540.
year: '2022'
doi: 10.3390/ijms23179540
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: Alzheimer’s disease | diabetes | glycolysis | ROS | genetic mutation | therapy
automl_pathway: 0.6237452
figid_alias: PMC9455726__F5
figtype: Figure
organisms_ner:
- Drosophila melanogaster
redirect_from: /figures/PMC9455726__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9455726__ijms-23-09540-g005.html
  '@type': Dataset
  description: Proteolytic cleavage of APP. In the non-amyloidogenic pathway, the
    extracellular domain cleavages by α-secretase and releases the soluble peptide
    sAPPα. In contrast, the amyloidogenic pathway releases Aβ42, a significant component
    of Aβ plaques.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - lds
  - ab
  - Appl
  - app
  - ApepP
  - APP-BP1
  - im
  - par
  - para
  - par-6
  - babo
  - bab1
  - bab2
---
